Pure Health Holding PJSC (ADX:PUREHEALTH)
United Arab Emirates · Delayed Price · Currency is AED 2.450
-0.050 (-2.00%)
At close: Nov 2, 2026
Pure Health Holding PJSC Income Statement
Financials in millions AED. Fiscal year is January - December.
Millions AED. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 29,633 | 27,312 | 25,848 | 16,399 | 12,486 | |
Revenue Growth | 9.78% | 5.66% | 57.62% | 31.34% | - |
Cost of Revenue | 22,389 | 20,579 | 19,202 | 12,976 | 7,656 |
Gross Profit | 7,244 | 6,733 | 6,646 | 3,423 | 4,830 |
Selling, General & Admin | 5,105 | 4,775 | 4,669 | 2,762 | 2,326 |
Other Operating Expenses | -902.78 | -708.78 | -316.99 | -841.02 | -1,378 |
Operating Expenses | 4,202 | 4,066 | 4,352 | 1,921 | 948.35 |
Operating Income | 3,041 | 2,666 | 2,294 | 1,502 | 3,881 |
Interest Expense | -977.69 | -852.69 | -825.28 | -78.22 | -44.56 |
Interest & Investment Income | 340.31 | 340.31 | 304.05 | - | - |
Other Non Operating Income (Expenses) | -12.16 | -12.16 | -22.36 | -39.26 | - |
EBT Excluding Unusual Items | 2,392 | 2,142 | 1,750 | 1,384 | 3,837 |
Impairment of Goodwill | - | - | - | - | -0.27 |
Gain (Loss) on Sale of Investments | 43.9 | 43.9 | 68.18 | - | - |
Gain (Loss) on Sale of Assets | 12.23 | 12.23 | 25.37 | -0.61 | -19.11 |
Asset Writedown | 43.34 | 43.34 | -65.84 | - | -7.01 |
Other Unusual Items | 0.8 | 0.8 | - | - | 475.46 |
Pretax Income | 2,492 | 2,242 | 1,778 | 1,384 | 4,286 |
Income Tax Expense | 253.01 | 222.01 | 62.04 | 418.7 | - |
Earnings From Continuing Operations | 2,239 | 2,020 | 1,716 | 964.95 | 4,286 |
Minority Interest in Earnings | -17.99 | -17.99 | -4.09 | -0.29 | -567.45 |
Net Income | 2,221 | 2,002 | 1,712 | 964.66 | 3,718 |
Net Income to Common | 2,221 | 2,002 | 1,712 | 964.66 | 3,718 |
Net Income Growth | 21.67% | 16.97% | 77.44% | -74.06% | - |
Shares Outstanding (Basic) | 11,111 | 11,111 | 11,111 | 10,037 | 9,832 |
Shares Outstanding (Diluted) | 11,111 | 11,111 | 11,111 | 10,037 | 9,832 |
Shares Change | - | -0.00% | 10.71% | 2.08% | - |
EPS (Basic) | 0.20 | 0.18 | 0.15 | 0.10 | 0.38 |
EPS (Diluted) | 0.20 | 0.18 | 0.15 | 0.10 | 0.38 |
EPS Growth | 21.67% | 16.97% | 60.27% | -74.59% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 2,997 | 3,990 | 3,442 | 2,142 | 3,955 |
Free Cash Flow Per Share | 0.27 | 0.36 | 0.31 | 0.21 | 0.40 |
Dividend Per Share | 0.054 | 0.054 | 0.031 | - | - |
Dividend Growth | 74.94% | 74.94% | - | - | - |
Gross Margin | 24.45% | 24.65% | 25.71% | 20.87% | 38.68% |
Operating Margin | 10.26% | 9.76% | 8.87% | 9.16% | 31.09% |
Profit Margin | 7.50% | 7.33% | 6.62% | 5.88% | 29.78% |
Free Cash Flow Margin | 10.12% | 14.61% | 13.31% | 13.06% | 31.67% |
EBITDA | 4,065 | 3,530 | 3,165 | 2,221 | 4,166 |
EBITDA Margin | 13.72% | 12.92% | 12.24% | 13.54% | 33.37% |
D&A For EBITDA | 1,024 | 863.47 | 870.94 | 719.19 | 284.93 |
EBIT | 3,041 | 2,666 | 2,294 | 1,502 | 3,881 |
EBIT Margin | 10.26% | 9.76% | 8.87% | 9.16% | 31.09% |
Effective Tax Rate | 10.15% | 9.90% | 3.49% | 30.26% | - |